Health

Results: 385-396 of 8091

Essity completes the acquisition of Edgewell's feminine care business

PR Newswire associated0

Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities

Wellcome Awards £5.3m Grant to Wysa

PR Newswire associated0

Morphic Medical Announces NUB Status One for RESET® Endoscopic Device Therapy in Germany

AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need

3Shape TRIOS 6 intraoral scanner wins the European Product Design Award (EPDA) 2025

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead

Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission

PR Newswire associated0

2,000 push-ups in 23 days: Are you up for the Challenge, United Kingdom?

PR Newswire associated0

WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China

Lorient’s low degree of modification delivers a smooth injection experience and high biocompatibility (Image: Lorient)

High-end Aesthetic Brand ‘Lorient’ Gains Global Prestige at IMCAS 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU